vs

Side-by-side financial comparison of FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $44.3M, roughly 1.7× FIRST BUSINESS FINANCIAL SERVICES, INC.). On growth, FIRST BUSINESS FINANCIAL SERVICES, INC. posted the faster year-over-year revenue change (8.5% vs -36.9%). Over the past eight quarters, FIRST BUSINESS FINANCIAL SERVICES, INC.'s revenue compounded faster (8.0% CAGR vs -34.4%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

FBIZ vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.7× larger
MED
$75.1M
$44.3M
FBIZ
Growing faster (revenue YoY)
FBIZ
FBIZ
+45.4% gap
FBIZ
8.5%
-36.9%
MED
Faster 2-yr revenue CAGR
FBIZ
FBIZ
Annualised
FBIZ
8.0%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FBIZ
FBIZ
MED
MED
Revenue
$44.3M
$75.1M
Net Profit
$12.2M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
27.5%
Revenue YoY
8.5%
-36.9%
Net Profit YoY
9.2%
EPS (diluted)
$1.44
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIZ
FBIZ
MED
MED
Q1 26
$44.3M
Q4 25
$42.2M
$75.1M
Q3 25
$44.5M
$89.4M
Q2 25
$41.0M
$105.6M
Q1 25
$40.8M
$115.7M
Q4 24
$41.2M
$119.0M
Q3 24
$38.1M
$140.2M
Q2 24
$38.0M
$168.6M
Net Profit
FBIZ
FBIZ
MED
MED
Q1 26
$12.2M
Q4 25
$13.3M
Q3 25
$14.4M
$-2.3M
Q2 25
$11.4M
$2.5M
Q1 25
$11.2M
$-772.0K
Q4 24
$14.4M
Q3 24
$10.5M
$1.1M
Q2 24
$10.5M
$-8.2M
Gross Margin
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
38.5%
-10.4%
Q3 25
39.0%
-4.6%
Q2 25
32.6%
-1.0%
Q1 25
33.0%
-1.1%
Q4 24
37.2%
0.6%
Q3 24
33.8%
1.5%
Q2 24
32.6%
-4.7%
Net Margin
FBIZ
FBIZ
MED
MED
Q1 26
27.5%
Q4 25
31.6%
Q3 25
32.3%
-2.5%
Q2 25
27.8%
2.3%
Q1 25
27.4%
-0.7%
Q4 24
35.0%
Q3 24
27.6%
0.8%
Q2 24
27.5%
-4.8%
EPS (diluted)
FBIZ
FBIZ
MED
MED
Q1 26
$1.44
Q4 25
$1.57
$-1.64
Q3 25
$1.70
$-0.21
Q2 25
$1.35
$0.22
Q1 25
$1.32
$-0.07
Q4 24
$1.69
$0.08
Q3 24
$1.24
$0.10
Q2 24
$1.23
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIZ
FBIZ
MED
MED
Cash + ST InvestmentsLiquidity on hand
$265.8M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
Total Assets
$4.3B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIZ
FBIZ
MED
MED
Q1 26
$265.8M
Q4 25
$39.5M
$167.3M
Q3 25
$44.3M
$173.5M
Q2 25
$123.2M
$162.7M
Q1 25
$170.6M
$164.6M
Q4 24
$157.7M
$162.3M
Q3 24
$132.0M
$170.0M
Q2 24
$81.1M
$163.5M
Stockholders' Equity
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
$371.6M
$198.9M
Q3 25
$358.3M
$214.7M
Q2 25
$344.8M
$216.0M
Q1 25
$336.1M
$211.0M
Q4 24
$328.6M
$210.1M
Q3 24
$312.0M
$207.3M
Q2 24
$305.2M
$205.3M
Total Assets
FBIZ
FBIZ
MED
MED
Q1 26
$4.3B
Q4 25
$4.1B
$248.0M
Q3 25
$4.0B
$268.2M
Q2 25
$4.0B
$269.3M
Q1 25
$3.9B
$280.0M
Q4 24
$3.9B
$284.2M
Q3 24
$3.7B
$291.2M
Q2 24
$3.9B
$293.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIZ
FBIZ
MED
MED
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
$61.7M
$-5.3M
Q3 25
$18.4M
$12.1M
Q2 25
$15.8M
$-3.4M
Q1 25
$11.3M
$3.4M
Q4 24
$57.5M
$-4.9M
Q3 24
$13.8M
$9.1M
Q2 24
$13.1M
$13.1M
Free Cash Flow
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
$61.1M
$-6.6M
Q3 25
$18.3M
$10.8M
Q2 25
$15.5M
$-4.8M
Q1 25
$11.2M
$1.9M
Q4 24
$57.3M
$-7.2M
Q3 24
$13.2M
$7.7M
Q2 24
$12.7M
$11.1M
FCF Margin
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
144.7%
-8.8%
Q3 25
41.0%
12.0%
Q2 25
37.8%
-4.5%
Q1 25
27.5%
1.6%
Q4 24
139.2%
-6.1%
Q3 24
34.6%
5.5%
Q2 24
33.3%
6.6%
Capex Intensity
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
1.4%
1.8%
Q3 25
0.3%
1.5%
Q2 25
0.8%
1.3%
Q1 25
0.2%
1.3%
Q4 24
0.5%
1.9%
Q3 24
1.6%
1.0%
Q2 24
1.1%
1.1%
Cash Conversion
FBIZ
FBIZ
MED
MED
Q1 26
Q4 25
4.63×
Q3 25
1.28×
Q2 25
1.39×
-1.36×
Q1 25
1.01×
Q4 24
3.99×
Q3 24
1.31×
8.04×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons